| 期 |
标题 |
文件 |
| 卷 24, 编号 2 (2024) |
A Retrospective Analysis of the Lauren Classification in the Choice of XELOX or SOX as an Adjuvant Chemotherapy for Gastric Cancer |
(Eng)
|
|
Wang K., Yu Y., Zhao J., Meng Q., Xu C., Ren J., Zhang Y., Wang Y., Wang G.
|
| 卷 24, 编号 5 (2024) |
Acknowledgements to Reviewers |
(Eng)
|
|
|
| 卷 24, 编号 4 (2024) |
AEG-1 as a Novel Therapeutic Target in Colon Cancer: A Study from Silencing AEG-1 in BALB/c Mice to Large Data Analysis |
(Eng)
|
|
Sriramulu S., Malayaperumal S., Banerjee A., Anbalagan M., Kumar M., Radha R., Liu X., Zhang H., Hu G., Sun X., Pathak S.
|
| 卷 24, 编号 2 (2024) |
Applications of Scaffolds in Tissue Engineering: Current Utilization and Future Prospective |
(Eng)
|
|
Yadav S., Khan J., Yadav A.
|
| 卷 24, 编号 5 (2024) |
Biogenesis and Function of circRNAs in Pulmonary Fibrosis |
(Eng)
|
|
Zhang S., Hu W., Lv C., Song X.
|
| 卷 24, 编号 4 (2024) |
Catechin Protects against Lipopolysaccharide-induced Depressive-like Behaviour in Mice by Regulating Neuronal and Inflammatory Genes |
(Eng)
|
|
Su Y., Qiu P., Cheng L., Zhang L., Peng W., Meng X.
|
| 卷 24, 编号 3 (2024) |
CRISPR-Based Therapies: Revolutionizing Drug Development and Precision Medicine |
(Eng)
|
|
Chanchal D., Chaudhary J., Kumar P., Agnihotri N., Porwal P.
|
| 卷 24, 编号 5 (2024) |
Current Landscape of Gene Therapy for the Treatment of Cardiovascular Disorders |
(Eng)
|
|
Wal P., Aziz N., Singh C., Rasheed A., Tyagi L., Agrawal A., Wal A.
|
| 卷 24, 编号 2 (2024) |
Current Updates on the Role of MicroRNA in the Diagnosis and Treatment of Neurodegenerative Diseases |
(Eng)
|
|
Saleem A., Javed M., Furqan Akhtar M., Sharif A., Akhtar B., Naveed M., Saleem U., Ashraf Baig M., Zubair H., Bin Emran T., Saleem M., Ashraf G.
|
| 卷 24, 编号 1 (2024) |
Development of Oral Bio-banks Past, Present and Future; Challenges and Opportunities |
(Eng)
|
|
Hiremath G., Omkarbabu K., Kokate M., Venkidasamy B., Krishnan M., Murugaiyan A.
|
| 卷 24, 编号 4 (2024) |
Direct Bilirubin, but not Indirect Bilirubin, is Associated with Short-term Adverse Events in HFpEF |
(Eng)
|
|
Wang S., Chen Y., Ma H., Wang Y., Luo M., Xie X., Yang Q., Lin K., Lin M., Lin L., Chen P., Zheng Q., Sun F.
|
| 卷 24, 编号 5 (2024) |
Dissecting the Mechanisms of Intestinal Immune Homeostasis by Analyzing T-Cell Immune Response in Crohn's Disease and Colorectal Cancer |
(Eng)
|
|
Jiang T., Zheng J., Li N., Li X., He J., Zhou J., Sun B., Chi Q.
|
| 卷 24, 编号 1 (2024) |
Duchenne Muscular Dystrophy Gene Therapy |
(Eng)
|
|
Saad F., Saad J., Siciliano G., Merlini L., Angelini C.
|
| 卷 24, 编号 5 (2024) |
Effect of Bovine Lactoferrin Treatment on Iron Homeostasis and Gene Expression Changes in Multiple Organ Dysfunctions During Wound Healing Process in Rats |
(Eng)
|
|
Bozkurt A., Yılmaz Ş.
|
| 卷 24, 编号 1 (2024) |
Effectiveness and Application Prospect of Microbiota-based Treatment |
(Eng)
|
|
Liang C.
|
| 卷 24, 编号 2 (2024) |
Exosome miR-30a-5p Regulates Glomerular Endothelial Cells' EndMT and Angiogenesis by Modulating Notch1/VEGF Signaling Pathway |
(Eng)
|
|
Ning Y., Zhou X., Wang G., Zhang L., Wang J.
|
| 卷 24, 编号 3 (2024) |
FIGNL1 Promotes Hepatocellular Carcinoma Formation via Remodeling ECM-receptor Interaction Pathway Mediated by HMMR |
(Eng)
|
|
Wang J., Sun L., Liu Y., Zhang Y.
|
| 卷 24, 编号 1 (2024) |
Gene Therapy for Rare Genetic Diseases |
(Eng)
|
|
Lundstrom K., Yannaki E., Chou J., Saad F.
|
| 卷 24, 编号 4 (2024) |
Hemophilia Healing with AAV: Navigating the Frontier of Gene Therapy |
(Eng)
|
|
Khan S., Khan M., Suleman M., Inam A., Din M.
|
| 卷 24, 编号 1 (2024) |
Identification of Important Genes Associated with the Development of Atherosclerosis |
(Eng)
|
|
Kotlyarov S.
|
| 卷 24, 编号 1 (2024) |
Innovative Genoceuticals in Human Gene Therapy Solutions: Challenges and Safe Clinical Trials of Orphan Gene Therapy Products |
(Eng)
|
|
Sharma R.
|
| 卷 24, 编号 1 (2024) |
Isoliquiritin Ameliorates Ulcerative Colitis in Rats through Caspase 3/HMGB1/TLR4 Dependent Signaling Pathway |
(Eng)
|
|
Miao Z., Gu M., Raza F., Zafar H., Huang J., Yang Y., Sulaiman M., Yan J., Xu Y.
|
| 卷 24, 编号 1 (2024) |
Meet the Editorial Board Member |
(Eng)
|
|
Chen X.
|
| 卷 24, 编号 2 (2024) |
Meet the Editorial Board Member |
(Eng)
|
|
Chiorini J.
|
| 卷 24, 编号 1 (2024) |
Non-coding RNAs in Regulation of Protein Aggregation and Clearance Pathways: Current Perspectives Towards Alzheimer's Research and Therapy |
(Eng)
|
|
Sundram S., Dhiman N., Malviya R., Awasthi R.
|
| 卷 24, 编号 3 (2024) |
Optogenetics: Illuminating the Future of Hearing Restoration and Understanding Auditory Perception |
(Eng)
|
|
Singh N., Ramamourthy B., Hage N., Kappagantu K.
|
| 卷 24, 编号 4 (2024) |
Potential Therapeutic Approach using Aromatic l-amino Acid Decarboxylase and Glial-derived Neurotrophic Factor Therapy Targeting Putamen in Parkinson's Disease |
(Eng)
|
|
Tripathi R., Goyal L., Singh S.
|
| 卷 24, 编号 5 (2024) |
Precision Genome Editing Techniques in Gene Therapy: Current State and Future Prospects |
(Eng)
|
|
Singh K., Bhushan B., Kumar S., Singh S., Macadangdang R., Pandey E., Varma A., Kumar S.
|
| 卷 24, 编号 3 (2024) |
Prediction of SARS-CoV-2 Infection Phosphorylation Sites and Associations of these Modifications with Lung Cancer Development |
(Eng)
|
|
Li W., Li G., Sun Y., Zhang L., Cui X., Jia Y., Zhao T.
|
| 卷 24, 编号 1 (2024) |
RNA Interference and Neuromuscular Diseases: A Focus on Hereditary Transthyretin Amyloidosis |
(Eng)
|
|
Ceccanti M., Inghilleri M.
|
| 卷 24, 编号 3 (2024) |
Segmentation of Thoracic Organs through Distributed Extraction of Visual Feature Patterns Utilizing Resio-Inception U-Net and Deep Cluster Recognition Techniques |
(Eng)
|
|
Saminathan K., Banerjee T., Rangasamy D., Vimal Cruz M.
|
| 卷 24, 编号 5 (2024) |
SHR6390 Combined with Cabozantinib Inhibits Tumor Progression in the Hepatocellular Carcinoma Mouse Model |
(Eng)
|
|
Liu C., Han P., Zhang Y., Wang Y., Nie J., Shan D., Zhou M., Lin B., Shi J., Zheng T.
|
| 卷 24, 编号 4 (2024) |
Single Injection AAV2-FGF18 Gene Therapy Reduces Cartilage Loss and Subchondral Bone Damage in a Mechanically Induced Model of Osteoarthritis |
(Eng)
|
|
Hollander J., Goraltchouk A., Liu J., Xu E., Luppino F., McAlindon T., Zeng L., Seregin A.
|
| 卷 24, 编号 2 (2024) |
Splicing DNA Damage Adaptations for the Management of Cancer Cells |
(Eng)
|
|
Singh A., Yadav D., Malviya R.
|
| 卷 24, 编号 5 (2024) |
The Functions and Application Prospects of Hepatocyte Growth Factor in Reproduction |
(Eng)
|
|
Mi X., Chen C., Feng C., Qin Y., Chen Z., Yang Y., Zhao S.
|
| 卷 24, 编号 3 (2024) |
Therapeutic Potential of CRISPR/Cas in Hashimoto's Thyroiditis: A Comprehensive Review |
(Eng)
|
|
Upreti A., Mukherjee S.
|
| 卷 24, 编号 2 (2024) |
Vector-Mediated Delivery of Transgenes and RNA Interference-Based Gene Silencing Sequences to Astrocytes for Disease Management: Advances and Prospectives |
(Eng)
|
|
Yadav D., Malviya R.
|
| 卷 24, 编号 5 (2024) |
ZNF695, A Potential Prognostic Biomarker, Correlates with Im mune Infiltrates in Cervical Squamous Cell Carcinoma and Endoce rvical Adenocarcinoma: Bioinformatic Analysis and Experimental Verification |
(Eng)
|
|
Ding X., Wan A., Qi X., Jiang K., Liu Z., Chen B.
|
| 1 - 38 的 38 信息 |
|
